Gapping up
In reaction to strong earnings/guidance:
- EBIX +6.7% (comments on change in auditor, says targeting FY19 revs of $650 mln+ vs $589.62 mln S&P Capital IQ Consensus Estimate) HELE +4.5%, PF +3.4% (guidance) KIM +1.1%
Other news:
- PYX +20.1% (after closing 37% higher on the day)
- PEIX +17.5% after closing more than 40% higher on the day)
- PZZA +8.8% (lifting on WSJ report of potential Trian Fund [Nelson Peltz] bid)
- GCAP +8.5% (commences modified Dutch auction tender offer to purchase up to $50 mln of shares of its common stock between $7.24-$7.94 per share)
- ZIOP +4.6% (ZIOPHARM & Intrexon (XON) subsidiary Precigen announce new definitive license agreement to replace all existing agreements between the companies)
- CGC +1.6% (increases licensed platform; 4.3 million square feet now licensed across Canada)
- YEXT +1.1% (light volume; initiated with Buy at DA Davidson), .
Analyst comments:
- BHGE +3.1% (upgraded to Buy from Hold at Jefferies)
- ESV +2.2% (upgraded to Outperform from Market Perform at Wells Fargo)
- MNR +1.2% (upgraded to Buy at B. Riley FBR)
- SCG +1% (upgraded to Buy from Neutral at Mizuho)
- TSLA +0.9% (initiated with Outperform and $430 tgt at Macquarie)
- NWSA +0.8% (upgraded to Buy from Neutral at Goldman)
- WMT +0.7% (upgraded to Buy from Hold at Deutsche Bank)
![]()